Treatments for chronic neuropathic, nociceptive and nociplastic pain

OLYS Pharma targets treatments for chronic painful inflammatory conditions by topical/transdermal modulation of pain neurotransmission and innate immune response to break the pro-inflammatory vicious circle of neurogenic inflammation.

Research also comprises using Dorsal Rooth Ganglia (DRG) for treating pain and organs presenting low grade inflammation and preventing brain remodelling.